A role for the high-density lipoprotein receptor SR-B1 in synovial inflammation via serum amyloid-A

American Journal of Pathology

Volumn 176, Issue 4, 2010, Pages 1999-2008

  Mullan, Ronan Hugh ^a   McCormick, Jennifer ^a   Connolly, Mary ^a   Bresnihan, Barry ^a   Veale, Douglas James ^a   Fearon, Ursula ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CYTOKINE; D37PA PEPTIDE; HIGH DENSITY LIPOPROTEIN RECEPTOR; INTERLEUKIN 6; L 37PA PEPTIDE; PEPTIDE DERIVATIVE; SCAVENGER RECEPTOR B1 ANTIBODY; SCAVENGER RECEPTOR BI; SERUM AMYLOID A; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOLOGY; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYNOVITIS; SYNOVIUM; UPREGULATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

EID: 77950578125     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090014     Document Type: Article

References (68)

1. Koch AE: c17 Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2000, 59 Suppl 1:i65-71
2. Fisher KL, Lu J, Riddle L, Kim KJ, Presta LG, Bodary SC: c17 Identification of the binding site in intercellular adhesion molecule 1 for its receptor, leukocyte function-associated antigen 1. Mol Biol Cell 1997, 8:501-515 (Pubitemid 27171298)
3. Fearon U, Griosios K, Fraser A, Reece R, Emery P, Jones PF, Veale DJ: c17 Angiopoietins, growth factors, and vascular morphology in early arthritis. J Rheumatol 2003, 30:260-268 (Pubitemid 36152587)
4. Cawston TE, Milner JM, Catterall JB, Rowan AD: Cytokine synergy, collagenases and cartilage collagen breakdown. Biochem Soc Symp 2003, 125-133
5. Feldmann M, Brennan FM, Chantry D, Haworth C, Turner M, Abney E, Buchan G, Barrett K, Barkley D, Chu A, et al: c17 Cytokine production in the rheumatoid joint: implications for treatment. Ann Rheum Dis 1990, 49 Suppl 1:480-486 (Pubitemid 20254614)
6. Nagase H, Kashiwagi M: c17 Aggrecanases and cartilage matrix degradation. Arthritis Res Ther 2003, 5:94-103 (Pubitemid 36849755)
7. Uhlar CM, Burgess CJ, Sharp PM, Whitehead AS: c17 Evolution of the serum amyloid A (SAA) protein superfamily. Genomics 1994, 19:228-235
8. Urieli-Shoval S, Linke RP, Matzner Y: c17 Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol 2000, 7:64-69 (Pubitemid 30007690)
9. Malle E, De Beer FC: c17 Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996, 26:427-435 (Pubitemid 26226404)
10. Cabana VG, Feng N, Reardon CA, Lukens J, Webb NR, de Beer FC, Getz GS: c17 Influence of apoA-I and apoE on the formation of serum amyloid A-containing lipoproteins in vivo and in vitro. J Lipid Res 2004, 45:317-325 (Pubitemid 38228830)
11. Kushner I: c17 The phenomenon of the acute phase response. Ann NY Acad Sci 1982, 389:39-48 (Pubitemid 12013176)
12. Cunnane G, Grehan S, Geoghegan S, McCormack C, Shields D, Whitehead AS, Bresnihan B, Fitzgerald O: c17 Serum amyloid A in the assessment of early inflammatory arthritis. J Rheumatol 2000, 27:58-63 (Pubitemid 30058629)
13. Vallon R, Freuler F, Desta-Tsedu N, Robeva A, Dawson J, Wenner P, Engelhardt P, Boes L, Schnyder J, Tschopp C, Urfer R, Baumann G: Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J Immunol 2001, 166:2801-2807 (Pubitemid 32173521)
14. O'Hara R, Murphy EP, Whitehead AS, FitzGerald O, Bresnihan B: Local expression of the serum amyloid A and formyl peptide receptor-like 1 genes in synovial tissue is associated with matrix metallo-proteinase production in patients with inflammatory arthritis. Arthritis Rheum 2004, 50:1788-1799 (Pubitemid 38725091)
15. Zerega B, Pagano A, Pianezzi A, Ulivi V, Camardella L, Cancedda R, Cancedda FD: c17 Expression of serum amyloid A in chondrocytes and myoblasts differentiation and inflammation: possible role in cholesterol homeostasis. Matrix Biol 2004, 23:35-46 (Pubitemid 38686716)
16. He R, Sang H, Ye RD: Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003, 101:1572-1581 (Pubitemid 36182537)
17. Mullan RH, Bresnihan B, Golden-Mason L, Markham T, O'Hara R, FitzGerald O, Veale DJ, Fearon U: c17 Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-kappaB-dependent signal transduction pathway. Arthritis Rheum 2006, 54:105-114 (Pubitemid 43122193)
18. + T cells. J Immunol 1996, 156:1189-1195 (Pubitemid 26048116)
19. Hershkoviz R, Preciado-Patt L, Lider O, Fridkin M, Dastych J, Metcalfe DD, Mekori YA: Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion. Am J Physiol 1997, 273:C179-C187 (Pubitemid 27343964)
20. Xu L, Badolato R, Murphy WJ, Longo DL, Anver M, Hale S, Oppenheim JJ, Wang JM: A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J Immunol 1995, 155:1184-1190
21. Migita K, Kawabe Y, Tominaga M, Origuchi T, Aoyagi T, Eguchi K: Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Invest 1998, 78:535-539 (Pubitemid 28246977)
22. Sodin-Semrl S, Spagnolo A, Mikus R, Barbaro B, Varga J, Fiore S: c17 Opposing regulation of interleukin-8 and NF-kappaB responses by lipoxin A4 and serum amyloid A via the common lipoxin A receptor. Int J Immunopathol Pharmacol 2004, 17:145-156 (Pubitemid 39572170)
23. Baranova IN, Vishnyakova TG, Bocharov AV, Kurlander R, Chen Z, Kimelman ML, Remaley AT, Csako G, Thomas F, Eggerman TL, Patterson AP: Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J Biol Chem 2005, 280:8031-8040 (Pubitemid 40349701)
24. Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RG, Xu S, Krieger M: Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 1997, 272:13242-13249 (Pubitemid 27216752)
25. van der Westhuyzen DR, Cai L, de Beer MC, de Beer FC: Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J Biol Chem 2005, 280:35890-35895 (Pubitemid 41633856)
26. Bocharov AV, Baranova IN, Vishnyakova TG, Remaley AT, Csako G, Thomas F, Patterson AP, Eggerman TL: Targeting of scavenger receptor class B type I by synthetic amphipathic alpha-helical-containing peptides blocks lipopolysaccharide (LPS) uptake and LPS-induced pro-inflammatory cytokine responses in THP-1 monocyte cells. J Biol Chem 2004, 279:36072-36082 (Pubitemid 39100615)
27. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al: c17 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31:315-324
28. Kruithof E, De Rycke L, Vandooren B, De Keyser F, FitzGerald O, McInnes I, Tak PP, Bresnihan B, Veys EM, Baeten D: Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis. Arthritis Rheum 2006, 54:1795-1804 (Pubitemid 43877929)
29. Rooney T, Bresnihan B, Andersson U, Gogarty M, Kraan M, Schumacher HR, Ulfgren AK, Veale DJ, Youssef PP, Tak PP: Microscopic measurement of inflammation in synovial tissue: inter-observer agreement for manual quantitative, semiquantitative and computerised digital image analysis. Ann Rheum Dis 2007, 66:1656-1660 (Pubitemid 350205457)
30. Fairwell T, Hospattankar AV, Brewer HB Jr, Khan SA: Human plasma apolipoprotein C-II: total solid-phase synthesis and chemical and biological characterization. Proc Natl Acad Sci USA 1987, 84:4796-4800 (Pubitemid 17095838)
31. Remaley AT, Thomas F, Stonik JA, Demosky SJ, Bark SE, Neufeld EB, Bocharov AV, Vishnyakova TG, Patterson AP, Eggerman TL, Santamarina-Fojo S, Brewer HB: c17 Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J Lipid Res 2003, 44:828-836 (Pubitemid 37279685)
32. Tolboom TC, van der Helm-Van Mil AH, Nelissen RG, Breedveld FC, Toes RE, Huizinga TW: Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis. Arthritis Rheum 2005, 52:1999-2002
33. Seemayer CA, Kuchen S, Kuenzler P, Rihoskova V, Rethage J, Aicher WK, Michel BA, Gay RE, Kyburz D, Neidhart M, Gay S: Cartilage destruction mediated by synovial fibroblasts does not depend on proliferation in rheumatoid arthritis. Am J Pathol 2003, 162:1549-1557 (Pubitemid 36512838)
34. Arnon S, Litmanovitz I, Regev RH, Bauer S, Shainkin-Kestenbaum R, Dolfin T: c17 Serum amyloid A: An early and accurate marker of neonatal early-onset sepsis. J Perinatol 2007, 27:297-302 (Pubitemid 46647907)
35. Gruber AD, Linke RP: c17 Generalised AA-amyloidosis in a bat (Pipistrellus pipistrellus). Vet Pathol1996, 33:428-430
36. Mozes G, Friedman N, Shainkin-Kestenbaum R: c17 Serum amyloid A: an extremely sensitive marker for intensity of tissue damage in trauma patients and indicator of acute response in various diseases. J Trauma 1989, 29:71-74 (Pubitemid 19054226)
37. Santiago P, Roig-Lopez JL, Santiago C, Garcia-Arraras JE: c17 Serum amyloid A protein in an echinoderm: its primary structure and expression during intestinal regeneration in the sea cucumber Holothuria glaberrima. J Exp Zool 2000, 288:335-344 (Pubitemid 32003753)
38. Santiago-Cardona PG, Berrios CA, Ramirez F, Garcia-Arraras JE: c17 Lipopolysaccharides induce intestinal serum amyloid A expression in the sea cucumber Holothuria glaberrima. Dev Comp Immunol 2003, 27:105-110 (Pubitemid 36110469)
39. Badolato R, Wang JM, Murphy WJ, Lloyd AR, Michiel DF, Bausserman LL, Kelvin DJ, Oppenheim JJ: c17 Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med 1994, 180:203-209 (Pubitemid 24181069)
40. Badolato R, Wang JM, Stornello SL, Ponzi AN, Duse M, Musso T: c17 Serum amyloid A is an activator of PMN antimicrobial functions: induction of degranulation, phagocytosis, and enhancement of anti-Candida activity. J Leukoc Biol 2000, 67:381-386
41. Furlaneto CJ, Campa A: A novel function of serum amyloid A: A potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun 2000, 268:405-408
42. Hatanaka E, Furlaneto CJ, Ribeiro FP, Souza GM, Campa A: c17 Serum amyloid A-induced mRNA expression and release of tumor necrosis factor-alpha (TNF-alpha) in human neutrophils. Immunol Lett 2004, 91:33-37 (Pubitemid 38147743)
43. Kumon Y, Hosokawa T, Suehiro T, Ikeda Y, Sipe JD, Hashimoto K: c17 Acute-phase, but not constitutive serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cells. Amyloid 2002, 9:237-241 (Pubitemid 36132518)
44. Patel H, Fellowes R, Coade S, Woo P: c17 Human serum amyloid A has cytokine-like properties. Scand J Immunol 1998, 48:410-418 (Pubitemid 28459659)
45. Ribeiro FP, Furlaneto CJ, Hatanaka E, Ribeiro WB, Souza GM, Cassatella MA, Campa A: c17 mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflamm 2003, 12:173-178 (Pubitemid 36871853)
46. Kumon Y, Suehiro T, Itahara T, Ikeda Y, Hashimoto K: c17 Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus. Clin Biochem 1994, 27:469-473
47. Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, Braunwald E: c17 Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol 2000, 35:358-362 (Pubitemid 30125525)
48. Niederau C, Backmerhoff F, Schumacher B, Niederau C: c17 Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Hepato-gastroenterology 1997, 44:90-107 (Pubitemid 27096020)
49. Weinstein PS, Skinner M, Sipe JD, Lokich JJ, Zamcheck N, Cohen AS: c17 Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol 1984, 19:193-198 (Pubitemid 14171511)
50. Yang RZ, Lee MJ, Hu H, Pollin TI, Ryan AS, Nicklas BJ, Snitker S, Horenstein RB, Hull K, Goldberg NH, Goldberg AP, Shuldiner AR, Fried SK, Gong DW: Acute-phase serum amyloid A: an inflammatory adipokine and potential link between obesity and its metabolic complications. PLoS Med 2006, 3:e287 (Pubitemid 43987831)
51. Hyka N, Dayer JM, Modoux C, Kohno T, Edwards CK, 3rd, Roux-Lombard P, Burger D: Apolipoprotein A-I inhibits the production of interleukin-1beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood 2001, 97:2381-2389 (Pubitemid 32291485)
52. Nishimoto N, Yoshizaki K, Miyasaka N, Yamamoto K, Kawai S, Takeuchi T, Hashimoto J, Azuma J, Kishimoto T: Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum 2004, 50:1761-1769 (Pubitemid 38725087)
53. Hagihara K, Nishikawa T, Isobe T, Song J, Sugamata Y, Yoshizaki K: IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system. Biochem Biophys Res Commun 2004, 314:363-369 (Pubitemid 38084725)
54. Asquith DL, McInnes IB: c17 Emerging cytokine targets in rheumatoid arthritis. Curr Opin Rheumatol 2007, 19:246-251 (Pubitemid 46597461)
55. Smeets TJ, Barg EC, Kraan MC, Smith MD, Breedveld FC, Tak PP: c17 Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritis. Ann Rheum Dis 2003, 62:635-638
56. Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljan Z, Emery P, Nuki G, Pavelka K, Rau R, Rozman B, Watt I, Williams B, Aitchison R, McCabe D, Musikic P: Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998, 41:2196-2204 (Pubitemid 29009378)
57. Okamoto H, Katagiri Y, Kiire A, Momohara S, Kamatani N: c17 Serum amyloid A activates nuclear factor-kappaB in rheumatoid synovial fibroblasts through binding to receptor of advanced glycation end-products. J Rheumatol 2008, 35:752-756 (Pubitemid 351747112)
58. Cheng N, He R, Tian J, Ye PP, Ye RD: Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J Immunol 2008, 181:22-26
59. Forcheron F, Legedz L, Chinetti G, Feugier P, Letexier D, Bricca G, Beylot M: c17 Genes of cholesterol metabolism in human atheroma: overexpression of perilipin and genes promoting cholesterol storage and repression of ABCA1 expression. Arterioscler Thromb Vasc Biol 2005, 25:1711-1717 (Pubitemid 41098945)
60. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Bairey Merz CN, Sopko G, Olson MB, Reis SE: Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004, 109:726-732
61. Hoffman JS, Benditt EP. J Biol Chem 1982, 257:10518-10522
62. Lindhorst E, Young D, Bagshaw W, Hyland M, Kisilevsky R: Acute inflammation, acute phase serum amyloid A and cholesterol metabolism in the mouse. Biochim Biophys Acta 1997,1339:143-154 (Pubitemid 27193322)
63. Hayat S, Raynes JG: c17 Acute phase serum amyloid A protein increases high density lipoprotein binding to human peripheral blood mononuclear cells and an endothelial cell line. Scand J Immunol 2000, 51:141-146 (Pubitemid 30095760)
64. Delanghe JR, Langlois MR, De Bacquer D, Mak R, Capel P, Van Renterghem L, De Backer G: c17 Discriminative value of serum amyloid A and other acute-phase proteins for coronary heart disease. Atherosclerosis 2002, 160:471-476 (Pubitemid 34159343)
65. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, Levin M, Sjogren A, Rudemo M, Lystig TC, Carlsson B, Carlsson LM, Lonn M: Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression. FASEB J 2006, 20:1540-1542 (Pubitemid 44943823)
66. Salas-Salvado J, Bullo M, Garcia-Lorda P, Figueredo R, Del Castillo D, Bonada A, Balanza R: Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss. Int J Obes (Lond) 2006, 30:1714-1720 (Pubitemid 44863402)
67. Chan DC, Chen CJ, Chu HC, Chang WK, Yu JC, Chen YJ, Wen LL, Huang SC, Ku CH, Liu YC, Chen JH: c17 Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann Surg Oncol 2007, 14:84-93 (Pubitemid 44954274)
68. Calvo D, Gomez-Coronado D, Lasuncion MA, Vega MA: CLA-1 is an 85-kD plasma membrane glycoprotein that acts as a high-affinity receptor for both native (HDL, LDL, and VLDL) and modified (OxLDL and AcLDL) lipoproteins. Arterioscler Thromb Vasc Biol 1997, 17:2341-2349 (Pubitemid 28015966)